Our experienced team creates individualized weightmanagement plans, combining advanced injectable therapy with comprehensive care to help you reach your unique wellness goals in a supportive clinical setting
Gonzalez JS, Safren SA, Delahanty LM, Cagliero E, Wexler DJ, Meigs JB, et al
The NLRP3 inflammatory corpuscle -IL-1-PFKFB3 axis is a key regulator of glycolysis of macrophages, and targeting this axis may help to alleviate inflammation and restore the metabolic balance of macrophages (Inamdar et al., 2023)
22 and in 9.8% of subjects receiving 1.8 mg/day (LEAD-5)
That number rose to 1,816 prescriptions in 2024, which equaled a 1,680% increase
The clinical analog already exists